A study by Pepe et al revealed overexpression of HBA1, HBA2, and SNCA genes in muscle-invasive BC (MIBC) patients.[7] These genetic alterations are crucial in the oncogenesis and progression of BC, significantly influencing treatment response and prognosis. Here, HBA2 is linked to breast cancer.